// App-Quantinova.ai

1263-212 : THE DECREASE IN PLASMA BRAIN NATRIURETIC PEPTIDE LEVEL IN RESPONSE TO INTRAVENOUS ILOPROST DURING CLINICAL WORSENING MAY PREDICT OUTCOME IN PULMONARY HYPERTENSION

Researchers

Presenter

  • Cihangir Kaymaz

Principal Investigators

  • Nertila Poci

  • Tugba Aktemur

  • Selcuk Ozturk

  • Ozgur Y Akbal

  • Fatih Yilmaz

  • Hacer Ceren Tokgoz

  • Ibrahim Halil Tanboga

  • Nihal Ozdemir

Medical Centers

  • Kartal Kosuyolu Yuksek Ihtisas Training and Research Hospital, Istanbul, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Pulmonary arterial hypertension

  • Dyspnea

Biomarkers

  • B-type natriuretic peptide

  • Sustained virological response

Drug/Treatment

  • Hydroxyzine

  • Iloprost

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved